Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

Summary

This study will follow participants who completed the TED-C14-006 study. The purpose of this study is to evaluate the long-term safety and efficacy of teduglutide in pediatric participants with Short Bowel Syndrome (SBS). This study will also offer teduglutide treatment to eligible participants, regardless of treatment received in TED-C14-006 or SHP633-301.

Timeline

Start

2017-01-09

Primary completion

2020-11-05

Completion

2020-11-05

Publications

• Wendel D, Wales PW, Kocoshis S, Venick R, Carter B, Cohran V, Matthews C, Raphael BP, Robinson I, Hill S. Quality of life for pediatric patients with short bowel syndrome-associated intestinal failure treated with teduglutide. J Pediatr Gastroenterol Nutr. 2026 Jul;83(1):54-62. doi: 10.1002/jpn3.70358. Epub 2026 Mar 19.

Drugs

Indications